Pharming Group N.V.
PHARNasdaqHealthcare · Pharmaceutical Preparations · P7 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Morgan StanleyPassive (13G)Apr 7, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 5,355 | 1.0 | -34.8% |
| Apr 30, 2026 | 8,217 | 1.4 | -10.5% |
| Apr 15, 2026 | 9,179 | 1.0 | -28.8% |
| Mar 31, 2026 | 12,882 | 1.0 | -15.5% |
| Mar 13, 2026 | 15,251 | 1.0 | +33.9% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.